Often seen as an option of last resort for ventricular tachycardia, new research suggests catheter ablation could have a ...

Results of the VANISH-2 trial, building on prior research, further upheld superiority of catheter ablation over ...

The US guidelines are likely to change following the release of the VANISH2 results last year, Christine Albert anticipates.

HeartBeam rolled out an application for its 12-lead ECG synthesis software to the FDA, based on the data from the study.

Researchers sought to determine 1-year outcomes in patients being treated with tirzepatide who have atrial fibrillation.

Pulsed field ablation (PFA) technology made some advances with 12-month results for the Globe Pulsed Field System in ...

Researchers sought to examine the prevalence of mental health disorders among patients with CVD, including patients with ...

Accounting for mortality as competing risk, the Afib burden trended numerically in favor of the GLP-1 RA group (HR 0.85, 95% ...

Vektor Medical, a leader in non-invasive, AI-powered arrhythmia analysis technology, today announced the initiation of the ...

The benefit of GLP-1 therapy couldn’t be explained by weight loss, suggesting that some pleiotropic effects may be at work.